Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00728650 · ClinicalTrials.gov registry record
A Retrospective Review of Malignant Liver Tumors
A clinical trial of Liver Cancer, sponsored by University of Oklahoma.
- Completed
- Registry status
- 228
- Enrollment target
- 1
- Study location
NCT00728650: Completed study of Liver Cancer, sponsored by University of Oklahoma.
NCT00728650 is a study of Liver Cancer that has completed, run by University of Oklahoma. The registered enrollment target is 228 participants, below the 445-participant average among 78 other Liver Cancer trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00728650, a study of Liver Cancer, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- 228 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will review the treatment and outcomes of patients having primary and metastatic hepatic malignancies. Patients treated with surgical resection, percutaneous radiofrequency ablation (RFA), and transarterial chemoembolization (TACE) will be compared with patients not receiving these treatments. Tumor recurrence and survival data will be compared to the published literature to determine the efficacy of current treatment strategies in this patient population.
Conditions Studied
Study Locations (1)
Oklahoma
- The University of Oklahoma College of Medicine, Tulsa - Department of Surgery - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2003-10 |
| Est. Completion | 2011-06 |
What the finished NCT00728650 record still lists
NCT00728650 is an observational study that tracks outcomes without assigning an intervention. The registered 228 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 78 other Liver Cancer trials with a reported enrollment target (49% lower).
The record links to 1 condition, with Liver Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00728650 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT00728650 about?
NCT00728650 is a clinical study titled "A Retrospective Review of Malignant Liver Tumors". This study will review the treatment and outcomes of patients having primary and metastatic hepatic malignancies. Patients treated with surgical resection, percutaneous radiofrequency ablation (RFA), and transarterial chemoembolization (TACE) will be compared with patients not receiving these treatm...
What is the current status of trial NCT00728650?
This trial is currently completed. The enrollment target is 228 participants. The study started on 2003-10. Estimated completion is 2011-06.
What conditions does trial NCT00728650 study?
This clinical trial studies the following conditions: Liver Cancer.
Who is sponsoring clinical trial NCT00728650?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00728650 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00728650's enrollment target sits among peer trials
228 17th of 78 higher than 62 of 78 other Liver Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility Study of CBCT for IGRT in Cancer Patients
RECRUITING · NA
-
Collection of Blood From Patients With Cancer
RECRUITING
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
RECRUITING · NA
-
Multi-analyte Blood Test Clinical Trial
RECRUITING
-
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05107908 · 228 participants · NA
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
- NCT05547698 · 228 participants · NA
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
- NCT05630963 · 228 participants
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
- NCT06073665 · 228 participants · Phase 4
Dosing of LT4 in Older Individuals
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia